Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Feb 12th 2020, Crypto Chartbook – Consistently extracting profits

Consistently extracting profits In our chartbook publication from last week we published a chart with entry levels as a guide on when to enter the market. Briefly after publication, the first low risk price level was approached. Consequently we posted a screen...

We Should Let the Banks Burn Down

Bob Moriarty of 321 Gold explains why he believes banks should be allowed to fail. In later 2008 during what is now referred to as the Great Financial Crisis, government and financial managers had an opportunity to reset a badly out of balance banking system....

Calculate the Trading Strategies' Profitability like a Pro

Investors venture into cryptocurrency trading to gain profits. They employ customized trading strategies, portfolio management strategies, and progressive investment decisions throughout their trade. Due to the progressive nature of trading, tracking one&CloseCurlyQuote...

Analyst: Valero Energy's Q3/19 Numbers Trimmed, Q4/19 Outlook Improved

In a research report, Raymond James revisits and revises its Q3/19 projections on this company. In an Oct. 1 note, Raymond James analyst Justin Jenkins reported that Valero Energy Corp.'s (VLO:NYSE) adherence to a disciplined strategy continues to drive strong perfo...

Aquestive Therapeutics Shares Up on Pipeline Update and Raised Full-Year 2019 Guidance

Aquestive Therapeutics shares traded 20% higher today after the firm reported Q3/19 earnings and raised its FY/19 guidance. The firm states it expects to complete its NDA for Libervant buccal film near the end of this month. Yesterday afternoon, specialty pharmaceutic...

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...

Facing Low Oil Prices, Energy Firm Reduces 2020 Capex, Guidance

The latest moves of Frontera Energy in response to depressed oil prices and its ability to endure the downturn are addressed in a CIBC report. In a March 23 research note, CIBC analyst Dave Popowich reported that Frontera Energy Corp. (FEC:TSX; FECCF:OTCMKT...

MediciNova Shares Rise 40% on Plans to Initiate COVID-19 ARDS Clinical Trial

Shares of MediciNova traded higher after the company reported that it plans to initiate a clinical study of MN-166 (ibudilast) for COVID-19 acute respiratory distress syndrome. Biopharmaceutical company MediciNova, Inc. yesterday announced that "it will ...

Oil & Gas Major's Pending Assets Sale Uncertain

The status and potential implications of this deal involving BP as the seller are discussed in a Raymond James report. In an April 13 research note, Raymond James analyst Pavel Molchanov wrote that the pending sale of BP Plc's (BP:NYSE; BP:LSE) Alaska asse...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
1 2 3